<?xml version="1.0" encoding="UTF-8"?>
<item xmlns="http://omeka.org/schemas/omeka-xml/v5" itemId="3695" public="1" featured="0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://omeka.org/schemas/omeka-xml/v5 http://omeka.org/schemas/omeka-xml/v5/omeka-xml-5-0.xsd" uri="http://exhibits.library.stonybrook.edu/mfp/items/show/3695?output=omeka-xml" accessDate="2026-06-09T14:30:47+00:00">
  <fileContainer>
    <file fileId="2171">
      <src>http://exhibits.library.stonybrook.edu/mfp/files/original/90cbf0ef2fecb1d2f8f4d50ed2e2e274.pdf</src>
      <authentication>69d4884410e5a3dedd1e0f6020e642af</authentication>
      <elementSetContainer>
        <elementSet elementSetId="4">
          <name>PDF Text</name>
          <description/>
          <elementContainer>
            <element elementId="52">
              <name>Text</name>
              <description/>
              <elementTextContainer>
                <elementText elementTextId="102797">
                  <text>January 25, 1969
Dr. Edgar Grunewald
Geigy Pharmaceuticals

Ardsley,
Dear

New

York ldbdz

to,

Following your request, we have reviewed our ongoing
ketimipramine~ieipramine study. This second phase was under»
taken to compare the two compounds in a random assignnent,
blind basis following the peeliminary study (Sunnery II: 8-30-65)
and the protocol (3—20—63). The study began in April lees.
To date, 26 patients in the outapatient population of the
Metropolitan Hospital Community Mental Health Center satisfied
the criterion for admission to the study of exhibiting symptoms
of depression, retardation and endogenous features. Of these,
6 are classifieo as psychotic depressions; l7 as neurotic
depressions and 3 as schizo~affective disorders with depressive
symptoms. Fourteen patients were assigned to imipramine and l2
to ketimipramine. Twelve are in progress now.
Of l4 subjects, 6 completed the study period and a were

twaa—nv

:
L

,

incomplete (“drop—out“). The “drop~outs“ were with both drugs
to drug factors. 0f 3 ketimipramine
treated patients each improved and were discharged from the

and appear unrelated

clinic.
after 5

One

of the

drop—out

patients discontinued treatment

weeks therapy, and we have not been able to obtain a
follow—up. At her last visit, her symptoms were ameliorated.

'

Three patients completed the imipramine
much improved (2) and improved (l);

rated as

trial,

being

Secondary effects were few (excluoiny the possibility that
sone patients failed to return because of symptoms assuneo to
be drug related). hith imipramine, headaches and “burning, red
eyes“ (l) and nausea (l) were reported. With ketimipramine,

‘

�January 25, 1969
Dr. Edgar Grunewald
Geigy Pharmaceuticals

Ardsley,
Dear

New

York ldbdz

to,

Following your request, we have reviewed our ongoing
ketimipramine~ieipramine study. This second phase was under»
taken to compare the two compounds in a random assignnent,
blind basis following the peeliminary study (Sunnery II: 8-30-65)
and the protocol (3—20—63). The study began in April lees.
To date, 26 patients in the outapatient population of the
Metropolitan Hospital Community Mental Health Center satisfied
the criterion for admission to the study of exhibiting symptoms
of depression, retardation and endogenous features. Of these,
6 are classifieo as psychotic depressions; l7 as neurotic
depressions and 3 as schizo~affective disorders with depressive
symptoms. Fourteen patients were assigned to imipramine and l2
to ketimipramine. Twelve are in progress now.
Of l4 subjects, 6 completed the study period and a were

twaa—nv

:
L

,

incomplete (“drop—out“). The “drop~outs“ were with both drugs
to drug factors. 0f 3 ketimipramine
treated patients each improved and were discharged from the

and appear unrelated

clinic.
after 5

One

of the

drop—out

patients discontinued treatment

weeks therapy, and we have not been able to obtain a
follow—up. At her last visit, her symptoms were ameliorated.

'

Three patients completed the imipramine
much improved (2) and improved (l);

rated as

trial,

being

Secondary effects were few (excluoiny the possibility that
sone patients failed to return because of symptoms assuneo to
be drug related). hith imipramine, headaches and “burning, red
eyes“ (l) and nausea (l) were reported. With ketimipramine,

‘

�</text>
                </elementText>
              </elementTextContainer>
            </element>
          </elementContainer>
        </elementSet>
      </elementSetContainer>
    </file>
  </fileContainer>
  <collection collectionId="1">
    <elementSetContainer>
      <elementSet elementSetId="1">
        <name>Dublin Core</name>
        <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
        <elementContainer>
          <element elementId="50">
            <name>Title</name>
            <description>A name given to the resource</description>
            <elementTextContainer>
              <elementText elementTextId="1">
                <text>Correspondence</text>
              </elementText>
            </elementTextContainer>
          </element>
        </elementContainer>
      </elementSet>
    </elementSetContainer>
  </collection>
  <itemType itemTypeId="1">
    <name>Text</name>
    <description>A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text.</description>
  </itemType>
  <elementSetContainer>
    <elementSet elementSetId="1">
      <name>Dublin Core</name>
      <description>The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.</description>
      <elementContainer>
        <element elementId="50">
          <name>Title</name>
          <description>A name given to the resource</description>
          <elementTextContainer>
            <elementText elementTextId="36944">
              <text>Correspondence to: Grunewald, Edgar</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="51">
          <name>Type</name>
          <description>The nature or genre of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="36945">
              <text>Text</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="43">
          <name>Identifier</name>
          <description>An unambiguous reference to the resource within a given context</description>
          <elementTextContainer>
            <elementText elementTextId="36946">
              <text>mfp-05-00-023-1-062</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="40">
          <name>Date</name>
          <description>A point or period of time associated with an event in the lifecycle of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="36947">
              <text>1969 </text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="39">
          <name>Creator</name>
          <description>An entity primarily responsible for making the resource</description>
          <elementTextContainer>
            <elementText elementTextId="36948">
              <text>&lt;a title="Fink, Max, 1923-" href="http://id.loc.gov/authorities/names/n79039548" target="_blank"&gt;Fink, Max, 1923-&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="49">
          <name>Subject</name>
          <description>The topic of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="36949">
              <text>Correspondence -- Correspondence</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="46">
          <name>Relation</name>
          <description>A related resource</description>
          <elementTextContainer>
            <elementText elementTextId="36950">
              <text>The Max Fink Collection</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="41">
          <name>Description</name>
          <description>An account of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="36951">
              <text/>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="47">
          <name>Rights</name>
          <description>Information about rights held in and over the resource</description>
          <elementTextContainer>
            <elementText elementTextId="36952">
              <text>&lt;a title="IN COPYRIGHT - EDUCATIONAL USE PERMITTED" href="http://rightsstatements.org/vocab/InC-EDU/1.0/" target="_blank"&gt;IN COPYRIGHT - EDUCATIONAL USE PERMITTED&lt;/a&gt;</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="48">
          <name>Source</name>
          <description>A related resource from which the described resource is derived</description>
          <elementTextContainer>
            <elementText elementTextId="36953">
              <text>Special Collections and University Archives, University Libraries. Stony Brook University Libraries (State University of New York).</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="44">
          <name>Language</name>
          <description>A language of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="77897">
              <text>en-US</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="42">
          <name>Format</name>
          <description>The file format, physical medium, or dimensions of the resource</description>
          <elementTextContainer>
            <elementText elementTextId="84458">
              <text>application/pdf</text>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="45">
          <name>Publisher</name>
          <description>An entity responsible for making the resource available</description>
          <elementTextContainer>
            <elementText elementTextId="91019">
              <text/>
            </elementText>
          </elementTextContainer>
        </element>
        <element elementId="37">
          <name>Contributor</name>
          <description>An entity responsible for making contributions to the resource</description>
          <elementTextContainer>
            <elementText elementTextId="97580">
              <text/>
            </elementText>
          </elementTextContainer>
        </element>
      </elementContainer>
    </elementSet>
  </elementSetContainer>
  <tagContainer>
    <tag tagId="4">
      <name>Correspondence</name>
    </tag>
  </tagContainer>
</item>
